BioXcel Therapeutics, Inc. (BTAI)
Confidential investigation: officers & directors’ potential breach of fiduciary duties to investors.
Investigation
04/04/2022
Initial Lawsuit
04/12/2022
Lawsuit Progression
06/13/2022
Whether Elon Musk’s failure to disclose his 5% ownership of Twitter on time violates Section 13(d) of the Exchange Act and SEC Rule 13d-1 promulgated thereunder, 17 C.F.R. § 240.13d-1(a).
When Elon Musk filed the required Schedule 13 revealing his ownership stake in Twitter, the company’s shares rose about 27%. Musk may have been motivated to delay the Schedule 13 filing to acquire shares of Twitter less expensively.
04/04/2022
Elon Musk files a Schedule 13G with the U.S. Securities and Exchange Commission (SEC) revealing an ownership stake in Twitter: 73,486,938 shares held by the Elon Musk Revocable Trust dated July 22, 2003 for which Elon Musk is the sole Trustee, or 9.2% of the company.
Stock Impact
Close | Previous close | Price variation | Percentage variation |
---|---|---|---|
$49.97 | $39.31 | $10.66 | 27.12% |
This is a federal securities class action on behalf of all investors who sold or otherwise disposed of Twitter, Inc. securities between March 24, 2022, and April 1, 2022, inclusive.
According to the complaint, defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the company’s business, operations, and prospects. Specifically, defendants allegedly failed to disclose to investors that:
(i) Elon R. Musk had acquired a 5% ownership stake in Twitter as required by Section 13(d) of the Exchange Act and SEC Rule 13d-1 promulgated thereunder, 17 C.F.R. § 240.13d-1.
The lead plaintiff deadline has passed, we will update this page as the lawsuit progresses.
Last event retrieved on 09/17/2022.
Confidential investigation: officers & directors’ potential breach of fiduciary duties to investors.